-
1
-
-
40149084615
-
Effect of growth inhibition on tumour cells induced by N3-O-toluyl-fluorouracil
-
J. Liu, W. F. Xu, Y. Zhou, Y. X. Yuan, and X. J. Qu, Effect of growth inhibition on tumour cells induced by N3-O-toluyl-fluorouracil. Chin. Pharm. J. 37, 252 (2006).
-
(2006)
Chin. Pharm. J
, vol.37
, pp. 252
-
-
Liu, J.1
Xu, W.F.2
Zhou, Y.3
Yuan, Y.X.4
Qu, X.J.5
-
2
-
-
32544436574
-
Nano-oncology: Drug delivery, imaging, and sensing
-
N. G. Portney and M. Ozkan, Nano-oncology: Drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 384, 620 (2006).
-
(2006)
Anal. Bioanal. Chem
, vol.384
, pp. 620
-
-
Portney, N.G.1
Ozkan, M.2
-
4
-
-
14644399827
-
Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release
-
T. L. Andresen, S. S. Jensen, and K. Jorgensen, Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog. Lipid. Res. 44, 68 ((2005).
-
(2005)
Prog. Lipid. Res
, vol.44
, pp. 68
-
-
Andresen, T.L.1
Jensen, S.S.2
Jorgensen, K.3
-
5
-
-
17644391325
-
Liposomal drug delivery systems - Clinical applications
-
P. Goyal, K. Goyal, S. G. Vijaya Kumar, A. Singh, O. P. Katare, and D. N. Mishra, Liposomal drug delivery systems - Clinical applications. Acta Pharm. 55, 1 (2005).
-
(2005)
Acta Pharm
, vol.55
, pp. 1
-
-
Goyal, P.1
Goyal, K.2
Vijaya Kumar, S.G.3
Singh, A.4
Katare, O.P.5
Mishra, D.N.6
-
6
-
-
0034992134
-
Trends and developments in liposome drug delivery systems
-
T. Lian and R. J. Ho, Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90, 667 (2001).
-
(2001)
J. Pharm. Sci
, vol.90
, pp. 667
-
-
Lian, T.1
Ho, R.J.2
-
7
-
-
0020955440
-
Toxicity of some charged lipids used in liposome preparation
-
P. I. Campbell, Toxicity of some charged lipids used in liposome preparation. Cytobios. 37, 21 (1983).
-
(1983)
Cytobios
, vol.37
, pp. 21
-
-
Campbell, P.I.1
-
8
-
-
54549116948
-
Studies on N3-O-toluyl-fluorouracil (TFu) liposomes
-
W. T. Sun, N. Zhang, A. G. Li, and W. F. Xu, Studies on N3-O-toluyl-fluorouracil (TFu) liposomes. Chin. Pharm. J. 42, 65 (2007).
-
(2007)
Chin. Pharm. J
, vol.42
, pp. 65
-
-
Sun, W.T.1
Zhang, N.2
Li, A.G.3
Xu, W.F.4
-
9
-
-
0000856178
-
A study of particulate intestinal absorption and hepatocellular uptake
-
E. Sanders and C. T. Ashworth, A study of particulate intestinal absorption and hepatocellular uptake. Exp. Cell. Res. 22, 37 ( 1961).
-
(1961)
Exp. Cell. Res
, vol.22
, pp. 37
-
-
Sanders, E.1
Ashworth, C.T.2
-
10
-
-
0028235218
-
Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles
-
A. M. Hillery, P. U. Jani, and A. T. Florence, Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug Targeting 2, 151 (1994).
-
(1994)
J. Drug Targeting
, vol.2
, pp. 151
-
-
Hillery, A.M.1
Jani, P.U.2
Florence, A.T.3
-
11
-
-
0026730479
-
Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat
-
P. U. Jani, A. T. Florence, and D. E. McCarthy, Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84, 245 (1992).
-
(1992)
Int. J. Pharm
, vol.84
, pp. 245
-
-
Jani, P.U.1
Florence, A.T.2
McCarthy, D.E.3
-
12
-
-
0029092672
-
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
-
A. T. Florence, A. M. Hillery, N. Hussain. and P. U. Jani, Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate. J. Control. Release 36, 39 (1995).
-
(1995)
J. Control. Release
, vol.36
, pp. 39
-
-
Florence, A.T.1
Hillery, A.M.2
Hussain, N.3
Jani, P.U.4
-
13
-
-
0018118085
-
Effects of bile salts on the structural integrity of liposomes
-
M. H. Richards and C. R. Gardner, Effects of bile salts on the structural integrity of liposomes. Biochim. Biophys. Acta 543, 508 (1978).
-
(1978)
Biochim. Biophys. Acta
, vol.543
, pp. 508
-
-
Richards, M.H.1
Gardner, C.R.2
-
14
-
-
0019859228
-
Can intact liposomes be absorbed in the gut?
-
D. S. Deshmukh, W. D. Bear, and H. Brockerhoff, Can intact liposomes be absorbed in the gut? Life Sci. 28, 239 (1980).
-
(1980)
Life Sci
, vol.28
, pp. 239
-
-
Deshmukh, D.S.1
Bear, W.D.2
Brockerhoff, H.3
-
15
-
-
0029881522
-
Induction of pneumoccocol polysaccharide specific mucosal immune responses by oral immunization
-
J. L. Vancott, T. Kobayashi, M. Yamamoto, J. R. McGhee, and H. Kiyono, Induction of pneumoccocol polysaccharide specific mucosal immune responses by oral immunization. Vanccine 14, 392 (1996).
-
(1996)
Vanccine
, vol.14
, pp. 392
-
-
Vancott, J.L.1
Kobayashi, T.2
Yamamoto, M.3
McGhee, J.R.4
Kiyono, H.5
-
16
-
-
62749146156
-
Study of in vitro and in vivo stability of liposomes loaded with calcitonin
-
A. Arien, C. Goigoux, C. Baquey, and B. Dupuy, Study of in vitro and in vivo stability of liposomes loaded with calcitonin. Life Sci. 53, 1297 (1993).
-
(1993)
Life Sci
, vol.53
, pp. 1297
-
-
Arien, A.1
Goigoux, C.2
Baquey, C.3
Dupuy, B.4
-
17
-
-
33847306474
-
Determination of encapsulation efficiencies of liposomes and nanoliposomes by protamine aggregation method
-
W. T. Sun, G. H. Huang, J. S. Ye, and N. Zhang, Determination of encapsulation efficiencies of liposomes and nanoliposomes by protamine aggregation method. Chin. Pharm. J. 41, 1716 (2006).
-
(2006)
Chin. Pharm. J
, vol.41
, pp. 1716
-
-
Sun, W.T.1
Huang, G.H.2
Ye, J.S.3
Zhang, N.4
-
18
-
-
0037133087
-
PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties
-
K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A. G. Karydas, and D. S. Ithakissios. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79, 123 (2002).
-
(2002)
J. Control. Release
, vol.79
, pp. 123
-
-
Avgoustakis, K.1
Beletsi, A.2
Panagi, Z.3
Klepetsanis, P.4
Karydas, A.G.5
Ithakissios, D.S.6
-
19
-
-
0000592382
-
The improved everted gut sac: A simple method to study intestinal P-glycoprotein
-
L. Barthe, M. Bessouet, J. F. Woodley, and G. Houin, The improved everted gut sac: A simple method to study intestinal P-glycoprotein. Int. J. Pharm. 173, 255 (1998).
-
(1998)
Int. J. Pharm
, vol.173
, pp. 255
-
-
Barthe, L.1
Bessouet, M.2
Woodley, J.F.3
Houin, G.4
-
20
-
-
0032035393
-
Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid
-
Y. J. Jung, J. S. Lee, H. H. Kim, and Y. M. Kim, Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid. Arch. Pharm. Res. 21, 174 ( 1998).
-
(1998)
Arch. Pharm. Res
, vol.21
, pp. 174
-
-
Jung, Y.J.1
Lee, J.S.2
Kim, H.H.3
Kim, Y.M.4
-
21
-
-
33646469307
-
Interaction of puerarin with phospholipid in Solid lipid dispersion
-
G. X. Zhai, H. X. Lou, D. Z. Bi, and L. J. Zoo, Interaction of puerarin with phospholipid in Solid lipid dispersion. J. Chin. Pharm. Sci. 12, 36 (2003).
-
(2003)
J. Chin. Pharm. Sci
, vol.12
, pp. 36
-
-
Zhai, G.X.1
Lou, H.X.2
Bi, D.Z.3
Zoo, L.J.4
-
22
-
-
0029080002
-
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
-
G. G. Liversidge and K. C. Cundy, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125, 91 (1995).
-
(1995)
Int. J. Pharm
, vol.125
, pp. 91
-
-
Liversidge, G.G.1
Cundy, K.C.2
-
23
-
-
0343488673
-
The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
-
J. Hunter and B. H. Hirst, The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug. Deliv. 25, 129 (1997).
-
(1997)
Adv. Drug. Deliv
, vol.25
, pp. 129
-
-
Hunter, J.1
Hirst, B.H.2
-
24
-
-
17144364276
-
Studies on drug release in vitro and rat intestinal absorption of tashinone. II A solid lipid nanoparticles
-
J. P Liu, Z. Y. Du, and L. Zhu, Studies on drug release in vitro and rat intestinal absorption of tashinone. II A solid lipid nanoparticles. Chin. Pharmacol. Bull. 21, 186 (2005).
-
(2005)
Chin. Pharmacol. Bull
, vol.21
, pp. 186
-
-
Liu, J.P.1
Du, Z.Y.2
Zhu, L.3
-
25
-
-
0345267135
-
Bioadhesion of solid oral dosage forms, why and how?
-
D. Duchêne and G. Ponchel, Bioadhesion of solid oral dosage forms, why and how? Eur. J. Pharm. Biopharm. 44, 15 (1997).
-
(1997)
Eur. J. Pharm. Biopharm
, vol.44
, pp. 15
-
-
Duchêne, D.1
Ponchel, G.2
-
26
-
-
0037436923
-
Bioadhesive microspheres as a controlled drug delivery system
-
J. K. Vasir, K. Tambwekar, and S. Garg, Bioadhesive microspheres as a controlled drug delivery system. Int. J. Pharm. 255, 13 (2003).
-
(2003)
Int. J. Pharm
, vol.255
, pp. 13
-
-
Vasir, J.K.1
Tambwekar, K.2
Garg, S.3
-
27
-
-
33746626869
-
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
-
Y. Luo, D. Chen, L. Ren, X. Zhao, and J. Qin, Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114, 53 (2006).
-
(2006)
J. Control. Release
, vol.114
, pp. 53
-
-
Luo, Y.1
Chen, D.2
Ren, L.3
Zhao, X.4
Qin, J.5
-
28
-
-
62749123295
-
Interaction of soybean phospholipids based lipo-vesicle and surfactants of bile salts in vitro
-
F. Q. Li, J. H. Hu, and Q. G. Zhu, Interaction of soybean phospholipids based lipo-vesicle and surfactants of bile salts in vitro. J. Chin. Pharm. Sci. 10, 136 (2001).
-
(2001)
J. Chin. Pharm. Sci
, vol.10
, pp. 136
-
-
Li, F.Q.1
Hu, J.H.2
Zhu, Q.G.3
-
29
-
-
0346494421
-
Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid lipid dispersions that combine fast- and slow-dissolving polymers
-
K. Six, G. Verreck, J. Peeters, M. Brewster, and G. Van den Mooter, Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid lipid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93, 124 ( 2004).
-
(2004)
J. Pharm. Sci
, vol.93
, pp. 124
-
-
Six, K.1
Verreck, G.2
Peeters, J.3
Brewster, M.4
Van den Mooter, G.5
|